Shekar Chelur

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Discovery of MAP855, an Efficacious and Selective MEK1/2 Inhibitor with an ATP-Competitive Mode of Action.
  Journal of medicinal chemistry 2022 8 citations DOI: 10.1021/acs.jmedchem.1c02192
  +Save
• Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies.
  ACS medicinal chemistry letters 2020 68 citations DOI: 10.1021/acsmedchemlett.0c00255
  +Save
• ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity.
  Molecular cancer therapeutics 2018 35 citations DOI: 10.1158/1535-7163.mct-18-0204
  +Save
• Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516.
  Bioorganic & medicinal chemistry letters 2017 12 citations DOI: 10.1016/j.bmcl.2017.11.006
  +Save
• 3-alkoxy-pyrrolo[1,2-b]pyrazolines as selective androgen receptor modulators with ideal physicochemical properties for transdermal administration.
  Journal of medicinal chemistry 2014 30 citations DOI: 10.1021/jm5009049
  +Save
• Expression of the fatty acid receptor GPR120 in the gut of diet-induced-obese rats and its role in GLP-1 secretion.
  PloS one 2014 65 citations DOI: 10.1371/journal.pone.0088227
  +Save
• Peptide hormone isoforms: N-terminally branched PYY3-36 isoforms give improved lipid and fat-cell metabolism in diet-induced obese mice.
  Journal of peptide science : an official publication of the European Peptide Society 2010 15 citations DOI: 10.1002/psc.1281
  +Save